2376. In Vitro Activities of Ceftaroline and Comparator Agents Against Bacterial Pathogens Collected From Patients With Skin and Skin Structure Infections in Latin America: AWARE Surveillance Program 2017

BACKGROUND: The parenteral cephem ceftaroline (CPT) fosamil is approved for the treatment of patients with skin and skin structure infections (SSSIs) caused by Staphylococcus aureus (both methicillin-susceptible [MSSA] and methicillin-resistant [MRSA] isolates), β-hemolytic streptococci (Streptococc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackel, Meredith, Karlowsky, James, Sahm, Dan, Stone, Gregory G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255484/
http://dx.doi.org/10.1093/ofid/ofy210.2029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255484/
http://dx.doi.org/10.1093/ofid/ofy210.2029

Ejemplares similares